
Stopping Transcranial Magnetic Stimulation (TMS) therapy can lead to two main outcomes: either symptoms return or improvements last. The direction depends heavily on how fully the initial treatment was completed and each person’s unique brain response.
TMS targets major depressive disorder, obsessive-compulsive disorder, and anxious depression, especially when medications fall short.
Patients often undergo 20 to 30 sessions over six to eight weeks, though how long benefits last varies widely. Some keep their progress for months, others notice symptoms creeping back. What follows is a look at what clinicians expect after stopping TMS, the risk of relapse, and ways to support lasting recovery. Keep reading to understand how this all plays out in practice.
Key Takeaways:
- Symptom outcomes after stopping TMS depend strongly on whether the full treatment course was completed
- Neuroplastic changes may persist for months after FDA-cleared TMS therapy ends
- Relapse risk increases when treatment is stopped early or without follow-up care
What Happens to Symptoms When You Stop TMS Therapy?
When TMS therapy ends, the path of symptoms varies. Some people keep their improvements for a long time. For others, symptoms can slowly return. The main factors are how the brain has changed from the treatment and whether the full treatment plan was finished.
TMS uses magnetic pulses to target parts of the brain involved in mood regulation, similar to the process explained in how NeuroStar Advanced TMS Therapy works. When the daily sessions stop, these stimulated areas may continue working better. Alternatively, they can gradually shift back toward their old, less effective patterns that are part of depression.
The Real-World Pattern After Treatment
In practice, I’ve seen a clear pattern emerge. While official studies talk about a 66% success rate for remission lasting a year, our clinic’s experience is different. The patients who do best aren’t just the ones who finish all their sessions. They’re the ones who start a maintenance plan for their wellness before any old symptoms even try to return.
The lasting benefit doesn’t just come from the 30 or so treatment sessions. It comes from what you do in the gap between the last pulse and the next twelve months. How durable the effect is depends on:
- The total dose of magnetic stimulation the brain received.
- The brain’s long-term adaptation to that stimulation.
- The presence of a concrete follow-up strategy.
For people with depression that hasn’t responded to other treatments, symptoms usually don’t bounce back overnight. Return often happens gradually, months after the therapy ends.
What Research Says About Long-Term Effects
The National Institute of Mental Health states that neuromodulation treatments, including TMS, can lead to lasting changes in the brain circuits that manage mood. These changes can persist after the therapy is finished.
Research connected to Harvard Medical School agrees. It notes that keeping these gains often requires a follow-up plan or a maintenance strategy once the initial treatment phase is over. Without a next step, the brain’s new patterns can fade.
What Happens if You Stop TMS Early Versus Finishing the Treatment?
In my experience, stopping TMS early is like stopping an antibiotic course because you feel better on day three, the underlying issue hasn’t been fully addressed. We see that the ‘build-up’ phase of TMS is cumulative.
If we cut the sessions short, we leave the brain’s mood-regulating circuits in a half-stimulated state, which is why relapse rates spike for those who don’t finish the protocol. If you stop partway through, that process is interrupted. The brain’s pathways don’t get the full chance to strengthen, so symptoms are more likely to come back.
Finishing the full course is different. It gives the brain the sustained stimulation it needs to make gradual, stable changes in the circuits that control mood. This helps lock in the improvement for longer.
Here’s a comparison of the two scenarios:
| Clinical Scenario | Expected Outcome | Neurobiological Effect |
| Mid-course discontinuation | High probability of relapse. | Incomplete cortical modulation. |
| Full treatment completion | Many patients experience symptom relief for 6 to 12 months. | Stabilized neuroplastic adaptation. |
The clinical evidence is clear: for FDA-cleared TMS therapy like NeuroStar, you see the best results when the entire protocol is completed. Stopping early often means the therapy doesn’t reach the level needed to create lasting changes in brain function.
How Long Do TMS Benefits Last After Treatment?

The positive effects from TMS can persist for many months after the final session. However, the exact timeline differs from person to person, and early indicators of response such as mood stabilization and energy changes often align with what are the signs that TMS is working? during the recovery phase.
How long the benefits last is influenced by the initial severity of the condition and whether any follow-up or maintenance sessions are used.
Data from clinical practice indicates that roughly two out of three patients maintain their improvement for six to twelve months after completing a full TMS course. A subset of patients may even see continued progress, as the brain’s activity continues to adjust. For individuals with treatment-resistant depression, the period of remission can be more variable and less certain.
A study available on PubMed Central notes that the durability of a patient’s response is inconsistent, but it generally strengthens when a structured maintenance plan is implemented.
Following the initial treatment phase, patients typically fall into one of three patterns: stable mood if they had a strong initial response, a gradual re-emergence of symptoms for partial responders, or sustained improvement when periodic booster sessions are added.
In summary, extending the benefits of TMS relies heavily on active post-treatment management and a plan for continued support.
What Are the Relapse Risks After Stopping TMS?
Ending TMS therapy doesn’t just turn off depression. Stopping treatment, especially before finishing the full recommended course, significantly increases the chance symptoms will come back. About one-third of patients experience some degree of symptom return within several months.
highlighted by National Institutes of Health (NIH)
“TMS is safe and effective in the treatment of MDD [Major Depressive Disorder], but as with other treatments, relapse may occur on cessation of treatment” . –Saxby Pridmore et al.
The risk of relapse is higher if treatment is discontinued prematurely or if there is no strategy for ongoing care. This risk is particularly pronounced for individuals with treatment-resistant depression.
Brain circuits are creatures of habit. TMS forces these pathways to fire in healthier patterns, but your brain can naturally ‘reset’ to its old, depressed state if the new habit isn’t locked in. Some patients also report transient cognitive changes, including what is sometimes discussed in relation to So TMS Cause Brain Frog during adjustment phases.
We use maintenance sessions to provide that necessary reinforcement, essentially reminding your neurons how to stay active and engaged. This reversal can lead to the return of low mood, increased anxiety (a common feature in anxious depression), and a noticeable decline in mental energy and drive.
However, the likelihood of relapse decreases when a clear maintenance plan is followed after the initial treatment phase. Regular monitoring and the option for periodic booster sessions help sustain the changes in brain activity and keep symptoms under control.
Can Maintenance or Booster Sessions Reduce Relapse After TMS?
Yes, booster sessions after an initial TMS course are a major factor in reducing the risk of relapse. I often tell my patients that ‘booster sessions’ are our most powerful tool for long-term remission.
While the 70% reduction in relapse is an impressive statistic from the literature, I’ve seen it play out in the clinic: patients who return for a single monthly session often bypass the ’emotional dip’ that usually happens around the six-month mark.
These follow-up sessions work by reactivating the specific neural pathways targeted during the primary treatment, helping to sustain their improved function over a longer period.
In a recent analysis by CNS Spectrums journal
“Our findings highly suggest that **lack of maintenance therapy when needed after completing TMS treatment with full remission may be a cause of relapse of depression in MDD patients. Following through with proper maintenance therapy will prevent relapse.” . –Sitwat Malik et al.
Maintenance isn’t just about more TMS, though. Combining these sessions with psychotherapy, particularly cognitive behavioral therapy (CBT), often leads to more durable stability for patients.
A typical maintenance strategy integrates periodic TMS appointments, ongoing medication management if applicable, and regular therapy. This multi-pronged approach supports the consolidation of treatment gains.
Increasingly, clinicians also emphasize supporting lifestyle habits that encourage natural neuroplasticity, such as consistent exercise and good sleep hygiene. These elements work alongside clinical interventions to help maintain the cortical activation patterns established by the original TMS treatment. Ultimately, maintenance therapy aims not only to prevent a setback but to solidify the brain’s adjusted state for the long term.
What Real-World Recovery Looks Like After TMS

Recovery after TMS ends doesn’t follow a uniform script. Patient outcomes vary significantly, particularly for those with treatment-resistant depression. Some individuals who responded well initially maintained their improvement for six to twelve months, experiencing no major symptom return.
For individuals exploring options like Advance TMS Therapy in FL, others encounter a gradual resurgence of symptoms, which may eventually necessitate another round of treatment.
If you feel your symptoms returning, don’t view it as a failure of the therapy. Many of my most successful long-term patients required a second ‘tune-up’ cycle. The encouraging news is that the brain remembers the previous stimulation; in fact, our success rates for a second round often hit 80%, as the neural pathways are already primed for change.
The brain’s capacity for change remains intact, allowing patients to recapture previous gains. This supports the view of TMS as a repeatable intervention within a long-term management strategy for depression, not merely a one-off procedure.
This variability underscores that recovery is often non-linear, involving phases of stability and periods of challenge. For a substantial number of patients, the key to preserving benefits lies in consistent follow-up and the willingness to re-engage with treatment when indicated.
When Is It Safe to Stop TMS Under Clinical Supervision?

Deciding to stop TMS should never be a casual choice. It requires a structured, supervised process based on the patient’s specific response and overall clinical picture.
Safe discontinuation typically follows the completion of a standard course, 20 to 30 sessions, as per FDA guidelines, and is contingent on achieving either remission or a significant, sustained reduction in symptoms.
The decision involves a thorough reassessment by the treating clinician. This evaluation determines whether stopping is appropriate or if modifications to the plan are warranted.
Treatment may be paused if potential neurological side effects arise, if the patient’s progress plateaus, or if the clinical focus transitions from acute treatment to a long-term maintenance strategy.
The cornerstone of a safe stop is a gradual, planned transition. A phased reduction in session frequency, rather than an abrupt halt, helps minimize the risk of a sudden symptom return and supports the durability of the therapeutic gains. Ending TMS is best viewed as a managed step within an ongoing care plan, not a final conclusion.
A Clinical Model for TMS Treatment Continuity

We don’t just offer a procedure; we manage your recovery. Our clinical pathway for NeuroStar Advanced TMS Therapy in FL is built specifically for those who haven’t found relief through traditional meds.
By integrating this non-invasive technology into your broader psychiatric care, we ensure that your treatment for MDD or anxious depression is supervised by experts who understand the nuances of brain stimulation.
Treatment Capabilities
NeuroStar TMS is a non-invasive, in-office procedure. It is administered under direct psychiatric supervision for the conditions listed above. Clinical trial data for treatment-resistant depression indicates an approximate 83% response rate and a 62% remission rate.
The therapy is intended to be used in conjunction with medication and psychotherapy. It requires no sedation, and patients can resume normal activities immediately after each session.
Reported side effects are typically mild and transient, most commonly involving scalp discomfort or headache at the treatment site. The treatment is covered by most major insurance providers across the United States, including Medicare and Tricare. Our clinic uses integrated technology to ensure precise dosing and to monitor clinical progress throughout the course.
Treatment Limitations
Patient safety is our baseline. Because TMS uses magnetic pulses, we cannot treat anyone with non-removable metal implants in the head area, think of it like the precautions you’d take for an MRI. While most of my patients find the sessions easy and return to work immediately, I always remind them that every brain is unique, and we tailor the intensity to your specific comfort level
Clinical summary
| Category | Clinical Details |
| FDA-cleared indication | For Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), and anxious depression. |
| Treatment model | Non-invasive neuromodulation. |
| Session range | A typical course is 20 to 30 sessions. |
| Response data | In clinical studies, about 83% of patients showed a response, and 62% achieved remission. |
| Side effect profile | Side effects are generally mild. The most common is temporary, localized discomfort at the scalp treatment site. |
| Insurance support | Eligible for coverage under Medicare and Tricare. |
| Limitations | Not recommended for patients with certain implanted metallic devices or a history of seizures. |
At Embracing Life Today, we use NeuroStar TMS as part of a complete psychiatric care plan. This isn’t just about providing a treatment session. Our approach focuses on achieving long-term stability, preventing future episodes, and building a personalized plan for each patient, especially those dealing with complex or treatment-resistant depression.
Stopping TMS Therapy: What You Should Expect
Stopping TMS therapy can lead to different outcomes depending on how far you are into treatment and how your brain responds. If therapy is completed, many people maintain improvement for longer.
If it’s stopped early, symptoms like low mood or anxiety can come back sooner. Without a follow-up plan, gains may fade over time and stability becomes harder to sustain.
Embracing Life Today offers structured psychiatric care and interventional options like TMS support, helping patients build maintenance plans that protect progress.
FAQ
What happens to depression after stopping TMS therapy?
After stopping TMS therapy, some patients stay well, while others notice depression returning after TMS. This depends on illness severity and follow-up care. Without maintenance, symptom recurrence after TMS is more likely. Regular monitoring helps detect early changes.
What happens months after TMS therapy ends to brain changes?
Months after TMS ends, brain activity continues adjusting as neuroplasticity after TMS stabilizes. Some patients keep improving, while others slowly notice symptom return. These changes reflect how TMS brain rewiring effects settle. Ongoing care helps maintain results longer.
How long do TMS results last and does effectiveness fade?
TMS results can last months or longer after treatment completion. In some cases, TMS effectiveness fading happens gradually over time. Long term results improve with maintenance care or therapy. Without support, symptoms may slowly return.
What is relapse risk after stopping transcranial magnetic stimulation therapy?
TMS relapse risk depends on history, stress, and severity of depression. Some patients experience depression rebound after TMS without follow-up care. Relapse prevention after TMS includes therapy and monitoring. Early action reduces symptom return risk.
Do patients need maintenance or booster sessions after TMS ends?
Many patients benefit from maintenance TMS sessions or booster sessions after treatment. These help maintain stability and reduce symptom recurrence. Follow-up care improves long term outcomes. It also supports sustained response after TMS.

